Phase I is a feasibility study, designed to establish the technical merit and commercial potential of a proposed R&D concept
Zone 2 (Europe excluding the EU): Aland Islands (Finland), Andorra, Albania, Armenia, Azerbaijan, Mount Athos (GR), Bosnia-Herzegovina, Campione d'Italia (IT), Ceuta (E), Faroe Islands (DK), Georgia, Gibraltar (GB), Greenland (DK), Guernsey (GB), Iceland, Jersey (GB), Canary Islands (E), Kazakhstan, Kosovo (Serbian province), Liechtenstein, Livigno (IT), Macedonia, Melilla (E), Moldova (Republic ), Montenegro (Republic), Norway, Russian Federation, San Marino, Serbia (Republic), Turkey, Ukraine, Vatican City, Belarus, Cyprus / Republic (North part) Zone 3 (World): Egypt, Algeria, Bahrain, Iran, Iraq, Israel, Yemen, Jordan, Qatar, Kuwait, Lebanon, Libya, Morocco, Oman, Saudi Arabia, Syria, Tunisia, United States, United Arab Emirates Zone 4 (Rest of World): All other countries and areas that are not listeted in zone 1, 2 and 3
At TrimRx, our clinical team emphasizes that these side effects are often manageable through small dietary changes, such as eating smaller meals and staying hydrated
when oxidative stress depletes GSH faster than it can be regenerated, the ratio collapses, signaling cellular redox imbalance
